The whole slide imaging market size is projected to reach US$ 2.45 billion by 2031 from US$ 0.64 billion in 2023. The market is expected to register a CAGR of 18.20% during 2023–2031. The utilization of artificial intelligence for better processing and outcomes is likely to remain a key trend in the market.
Whole slide imaging is the process of digitally scanning and storing as digital images a tissue slide that has thin sections of tissue specimens for microscopic inspection. This procedure enables remote analysis and collaboration with consideration for speed, usability, and image quality. The need for cutting-edge treatments and the rising incidence of chronic illnesses will probably lead to an increase in the number of research facilities and funding for this field. It is anticipated that these investments will present a profitable chance for market expansion. For researchers, whole slide imaging offers many advantages, including improved pathology workflow efficiency and remote reviewing and analysis. Therefore, the market is expected to grow due to significantly increasing investments in research and development made by both government agencies and industry participants.
A greater focus on attaining superior diagnostic results is significantly propelling the need for digital pathology. The biggest pathology companies in the country, academic health centers, and pathology departments all share a growing acceptance of digital pathology and whole-slide imaging. In the US, a large number of private practice pathology groups acknowledge that digital pathology represents the future of the field as a whole. The majority of large pathology lab companies and academic pathology departments have incorporated whole-slide imaging (WSI) and digital pathology (DP) into many of their lab's routine operations. As a result, major players are concentrating on introducing new products. First, the Bruker company Canopy Biosciences announced the introduction of the CellScape Whole-Slide Imaging Chamber, which will bring whole-slide spatial biology to the adaptable CellScape Precise Spatial Multiplexing platform in April 2024. With a total imaging area of 710 mm2, the new imaging chamber has the largest window of any microfluidic spatial biology instrument on the market. Additionally, the new imaging chamber facilitates a general decrease in the volumes of reagents needed for each sample. Whole slide imaging is predicted to become more popular as a result of the rising demand for digital pathology solutions; this will ultimately propel the market during the projected period.
In the latter part of the 1990s, whole slide imaging became popular. The system's initial phase involved taking pictures of composite slides using a combination of a microscope and a computer. On the other hand, the system's image acquisition took a long time. Technology companies employed high-speed systems and automated algorithms to increase the speed of image acquisition to get around this restriction. With this technological advancement, whole slide imaging has more applications. For example, in May 2021, the College of American Pathologists (CAP), in partnership with the American Society for Clinical Pathology (ASCP) and the Association for Pathology Informatics (API), updated the guideline "Validating Whole Slide Imaging for Diagnostic Purposes in Pathology" in response to the swift progress being made in clinical applications for whole slide imaging and digital pathology. With the new guidelines, patients will be guaranteed a speedy pathologic diagnosis and high-quality test results, potentially leading to earlier treatment. Whole slide imaging technologies are developing positively as a result of ongoing improvements in computational algorithms and image capture technologies. This technology is improving throughput, reducing errors, and enabling fast and effective image capture, image archiving, and image sharing. For example, Inspirata Inc. announced in March 2022 that the Dvnamyx digital pathology software had received FDA (Food and Drug Administration) clearance in the United States. With multiple scanners, Dvnamvx is the first company to receive FDA clearance for digital pathology software, allowing customers to choose the best scanners for their lab. With this clearance, Dvnamyx clients can use whole slide images (WSIs) rather than conventional glass slides for primary diagnosis, which has significant advantages for labs and pathologists. According to estimates, these technological advancements will encourage the use of whole slide imaging systems, which will ultimately accelerate market expansion throughout the forecast period.
Technologies related to telemedicine involve the use of contemporary communication channels to facilitate virtual communication between medical practitioners and patients. Additionally, the technology uses telecommunications to assist in the assessment, diagnosis, and treatment of patients. By using telemedicine technologies, patients and doctors can communicate across geographic boundaries. With the aid of intelligent algorithms, digital pathology in whole slide imaging provides a significant method for image archiving and thorough analysis, enabling medical professionals to access and examine images at any time and from any location. Growing investments and the significant benefit provided by telemedicine technologies are expected to present a profitable growth opportunity for the market over the forecast period.
Key segments that contributed to the derivation of the whole slide imaging market analysis are type, application, and end user.
The geographic scope of the whole slide imaging market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
In terms of the entire North American slide imaging market, the United States has the largest market share. Key growth drivers include the abundance of imaging centers in this area, the rapid advancement of technology, the aging population, and the rising need for computer-aided diagnosis. Moreover, the market is growing at an exponential rate due to the increasing prevalence of different kinds of neurological, oncological, and cardiovascular indications. Furthermore, the government's strategic initiatives will present more profitable chances for the nation. Also, the presence of various companies engaged in strategic agreements will propel market growth. For instance, Mikroscan Technologies, in March 2020, announced that it has entered into a non-exclusive distribution agreement with Inspirata Inc. Inspirata market and distribute Mikroscan’s digital pathology and telemicroscopy systems, the SL5 Dual-Mode Real-Time Telemicroscopy and Digital Pathology system and the L5 Real-Time Telemicroscopy system throughout the United States.
The regional trends and factors influencing the Whole Slide Imaging Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Whole Slide Imaging Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 0.64 Billion |
| Market Size by 2031 | US$ 2.45 Billion |
| Global CAGR (2023 - 2031) | 18.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Whole Slide Imaging Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Whole Slide Imaging Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The whole slide imaging market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the whole slide imaging market are listed below:
The “Whole Slide Imaging Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
North America dominated the whole slide imaging market in 2023
Key factors driving the market are the rising demand for digital pathology solutions and technological advancements in whole slide imaging.
The utilization of artificial intelligence for better processing and outcomes is likely to remain a key trend in the market.
Akoya Biosciences, Inc., Olympus, 3DHISTECH, Mikroscan Technologies, Indica Labs, Inspirata, Leica Biosystems, Visiopharm, Koninklijke Philips N.V., Hamamatsu Photonics K.K, Nikon
The market is expected to register a CAGR of 18.20% during 2023–2031.